Skip to main content
Neuropsychopharmacology Reports logoLink to Neuropsychopharmacology Reports
. 2025 Jun 14;45(2):e70030. doi: 10.1002/npr2.70030

Prevalence of Over‐the‐Counter Drug Abuse and Associated Psychosocial Factors Among High School Students: A Nationwide Cross‐Sectional Survey in Japan

Takuya Shimane 1,, Satoshi Inoura 1,2, Maki Kitamura 1, Kunihiko Kitagaki 3, Koji Tominaga 4, Toshihiko Matsumoto 1
PMCID: PMC12166313  PMID: 40515536

ABSTRACT

Aim

This study estimated the prevalence of over‐the‐counter (OTC) drug abuse among high school students in Japan and clarified the predictors related to their school and home life.

Methods

A nationwide cross‐sectional survey was conducted between September 2021 and March 2022. The survey included 41 357 valid responses from 202 randomly selected regular high schools in Japan. Respondents were asked about their history of OTC drug abuse within the past year, which was the primary outcome of this study. Multivariate logistic regression analyses were performed to identify the predictors of OTC drug abuse.

Results

The estimated prevalence of OTC drug abuse over the past year was 1.5% (95% CI: 1.4–1.6). Dissatisfaction with school life (AOR = 2.57, 95% CI = 1.80–3.66), hours spent in a day without parents (AOR = 1.59, 95% CI = 1.27–2.00), and COVID‐19‐related stress (AOR = 1.53, 95% CI = 1.14–2.05) significantly increased the risk of OTC drug abuse. Conversely, positive extracurricular activities (AOR = 0.80, 95% CI = 0.63–1.00), close communication with the mother (AOR = 0.66, 95% CI = 0.51–0.87), and high drug‐refusal skills (AOR = 0.57, 95% CI = 0.41–0.79) significantly reduced the risk.

Conclusions

OTC drug abuse is widespread among high school students in Japan, and attention should be paid to students who are isolated at school and home. Therefore, it is important to develop effective prevention, education, and treatment programs for adolescents that consider the risks and protective factors associated with OTC drug abuse.

Keywords: adolescent, epidemiologic research design, nonprescription drugs, social isolation, substance‐related disorders


A nationwide survey of Japanese high school students revealed the current state of over‐the‐counter drug abuse. The prevalence of over‐the‐counter drug abuse within the past year was estimated to be 1.5%. Risk and protective factors in school and home life were identified.

graphic file with name NPR2-45-e70030-g001.jpg

1. Introduction

Over‐the‐counter (OTC) drugs, purchased at pharmacies without a prescription, are familiar medicines in daily life. However, OTC drugs containing certain ingredients are abused, particularly by adolescents and young adults, and cause various health problems, such as acute intoxication and dependence [1, 2]. For example, cough and cold medicines containing dextromethorphan are typical OTC drugs that are abused [3, 4, 5]. The ingestion of high doses of dextromethorphan inhibits N‐methyl‐D‐aspartate (NMDA) receptors, causing hallucinogenic and dissociative effects [6, 7]. Cases of ingestion of high doses of dextromethorphan have reportedly resulted in assault, self‐harm, suicide, and murder [8]. This study focused on the abuse of OTC drugs, defined by the American College of Preventive Medicine as the self‐administration of medications to alter consciousness or “get high.” This definition guided our approach [9].

Studies on OTC drug abuse are limited compared to those on controlled substance abuse [10, 11, 12]. For example, studies in the UK [13] and Italy [14] reported OTC drug abuse prevalence, motivations, and risk factors among the general population. These reports provide useful information but have methodological shortcomings. In the study conducted in the UK, although random sampling was performed using the electoral register, the total sample size was 1000, and only about 400 participated in the survey. This small sample size affected representativeness. The Italian study had a larger sample size (approximately 700), but faced representativeness‐related issues due to recruiting participants through direct contact (e.g., acquaintances and students) and the Internet (e.g., emails, social media). Moreover, as these studies broadly targeted the general population, they were unable to obtain sufficient information on OTC drug abuse among adolescents and young adults.

In Japan, cases of OTC drug use disorders have risen significantly in recent years. According to a nationwide survey of psychiatric facilities, the proportion of such patients increased approximately six‐fold from 2012 to 2020 [15]. Secondary analysis of the survey data showed that these patients are predominantly young women with relatively high educational attainment and a low history of drug‐related crimes [16]. The most commonly abused OTC drugs include cough suppressants and cold medicines containing codeine or dihydrocodeine, consistent with trends in other countries. Additionally, painkillers containing bromovaleryl urea, which have been discontinued as medicines in many countries owing to intoxication and suicide risks, are still abused in Japan [17, 18].

Monitoring adolescent OTC drug abuse patterns through nationwide surveys is crucial for tackling adolescents' drug problems. Monitoring the Future (MTF), conducted by the University of Michigan in the United States, is the national dataset that has been reporting the prevalence of OTC drug abuse among school‐going adolescents since 2006 [19]. The MTF data show eighth graders' OTC drug abuse rose from 1.6% in 2015 to 4.6% in 2020, the highest since 2006, before declining to 3.2% in 2022; however, prevalence among tenth and twelfth graders remained stable.

To our knowledge, no nationwide epidemiological survey has been conducted on OTC drug abuse among adolescents in Asia, including Japan. Understanding adolescent OTC drug abuse requires assessing psychosocial factors, but such studies are less documented than those on illicit drug research. Therefore, this study aimed to examine the prevalence of OTC drug abuse among high school students in Japan and clarify the predictors of OTC drug abuse. This study is Asia's first large‐scale, random‐sample school survey on OTC drug abuse.

2. Methods

2.1. Study Design and Data Source

This study is a secondary analysis of the Nationwide High School Survey on Drug Use and Lifestyle 2021 [20]. This cross‐sectional survey examined Japanese high school students' current substance use and lifestyle statuses. This study was conducted at the National Center of Neurology and Psychiatry in Japan between September 2021 and March 2022 during the COVID‐19 pandemic.

The target population for the survey was 172 391 students enrolled in 202 high schools across the nation. The target schools were randomly selected through a stratified one‐stage community sampling method using six districts (Hokkaido‐Tohoku, Kanto, Hokuriku‐Tokai, Kinki, Chugoku‐Shikoku, and Kyushu‐Okinawa) as strata and each high school as a cluster. The inclusion criteria were regular high schools that held classes during the day, and the exclusion criteria were nighttime high schools that held classes at night and distance‐learning high schools that held classes online. Regular high school is a 3‐year educational program that mainly applies to students aged between 15 and 18. An anonymous self‐administered survey comprising 45 questions was conducted in high school classrooms. Questionnaires were distributed and collected by teachers at each school. Students completed the questionnaires in their classrooms, sealed them in individual envelopes, and submitted them to their teacher to minimize response bias.

The participants were informed in advance of the organization and purpose of the research, the voluntary nature of responses to the survey, and how the data would be used. The survey description was published on the Internet as a public notice and at the beginning of the questionnaire, which the teachers read before administering the survey. In this study, the informed consent procedure was omitted by guaranteeing participants the opportunity to refuse to participate. The study protocol was reviewed and approved by the Ethics Committee of the National Center of Neurology and Psychiatry (Approval no.: A2018‐055), and it conforms to the provisions of the Declaration of Helsinki.

2.2. Measures

2.2.1. Abuse of OTC Drugs

Participants were asked about their history of OTC drug abuse over the past year, which was the primary outcome of this study. The types of OTC drugs used were cough medicines, cold medicines, and analgesics. OTC drug abuse was defined as using a drug in excess of the prescribed amount or frequency to get high or change one's mood. Internationally, the term “abuse” has become stigmatized and is avoided, particularly in the medical field. Japanese law (Pharmaceutical Affairs Law) [21] uses the Japanese word “Ranyo,” which means “abuse,” which is why the term “abuse” is used in this study; however, the term “abuse” was not used in expressions toward individuals.

2.2.2. School Life‐Related Variables

In this study, variables related to school life, home life, and substance use were set as predictor variables based on previous studies on adolescent substance use. As a variable related to school life, this study asked participants about their level of satisfaction with school life, which was rated on a four‐point Likert scale ranging from “very satisfied” to “very dissatisfied.” This variable was based on reports that lower life satisfaction was associated with polysubstance use among high school students [22]. Additionally, this study examined the positive relationships between peers and extracurricular activities as protective factors against adolescent drug use [23]. The participants were asked to select one of four options based on their participation status: not participating, negatively participating, positively participating, or previously participated. Regarding positive relationships with peers [24], the following questions were asked: “Do you have close friends?” and “Do you have friends you can consult with?” with dichotomized options.

2.2.3. Home Life‐Related Variables

As a variable related to home life, participants were asked about the average number of hours spent per day without their parents. This question was based on parental monitoring and support, which are protective factors against substance use among adolescents [25]. We instructed the participants to exclude time spent at school, cram school, extracurricular activities, and exercise when calculating the time. Participants were required to select one answer from five response options (none, less than 1 h, 1–2 h, 2–3 h, and more than 3 h). Furthermore, the participants were asked how often they consulted their mothers and fathers when they had problems, using a four‐point scale (never, rarely, sometimes, and often). This question aimed to evaluate adolescents' help‐seeking behavior from parents when they had problems. Although we did not provide specific examples of types of problems in the question, we assumed typical areas requiring help would include studying at school, friendships, and future plans. Given that this study was conducted during the pandemic, COVID‐19‐related stress was assessed as a variable related to home life [26]. The participants were asked the following question: “Looking back over the past year, how stressed do you feel about the schools being forced to close and having to stay at home due to the COVID‐19 pandemic?” Stress levels were evaluated using a four‐point scale (none, low, moderate, and high).

2.2.4. Substance Use‐Related Variables

Participants were asked about their use of alcohol, tobacco, marijuana, organic solvents, methamphetamine, new psychoactive substances (NPS), cocaine, and MDMA within the past year. The substance types were based on survey items from a general population survey conducted in Japan [15]. Additionally, the participants were asked about their drug‐refusal skills, given that low refusal skills were a risk factor for substance use among adolescents [27, 28]. Drug refusal skills were assessed by examining self‐efficacy in refusing drugs. Participants responded to the question, “If a close friend or acquaintance encouraged you to use drugs, how confident are you in your ability to refuse?” using a four‐item Likert scale (none, low, moderate, and high).

2.3. Statistical Analysis

To examine the participants' characteristics, cross‐tabulations were performed with school location, area, grade, and age based on gender groups. The chi‐square test was used to verify significant differences between groups. In addition, to examine the bias among high school students across Japan, the national data were compared with the 2020 School Basic Survey [29], which was conducted following the Statistics Act of Japan, and significant differences were verified using a goodness‐of‐fit test.

The prevalence estimates of OTC drug abuse and other substance use were calculated by setting the probability of sampling students in each block as P1 and the probability of sampling survey respondents in each target school as P2. Weighting was calculated using the equation below; point estimates and standard errors were calculated.

P1=Number of students in target school/number of high school students in each block
P2=Number of studentswhoresponded to the survey/number of students in target schools weight=1/p1×1/p2

Multivariable logistic regression models were used to examine the risk of OTC drug abuse in relation to the potential predictors. OTC drug abuse within the past year was set as the dependent variable and items related to students' school and home life as explanatory variables. Variables reported as risk or protective factors for adolescent drug use in previous studies [22, 23, 24, 25, 26, 27, 28] were included in the models. Demographic variables such as gender, age, and substance use other than OTC drugs were also included in the model as possible confounders. When entering explanatory variables into the simultaneous logistic regression model, we confirmed that the number of events per variable was 10 or more, following the criterion set in previous studies. Variance inflation factor (VIF) was used to check for multicollinearity, and the Hosmer–Lemeshow test was used to check the goodness of fit of the model. Adjusted odds ratios (AORs) and 95% confidence intervals were calculated using logistic regression analysis. Statistical analyses were conducted using IBM SPSS ver. 29.

3. Results

3.1. Sample Demographics

In total, 44 789 students from 80 high schools responded to the self‐administered questionnaire. The response rate was 39.6% for the target schools and 26.0% for the students. A total of 3432 students lacking data were excluded, and the remaining 41 357 valid responses were used in this study. The demographic characteristics of the participants are presented in Table 1. Regarding participants' gender, 52.3% were females, 46.7% were males, and 1.0% were others or unknown. The most common geographic location of the high schools where the survey was conducted was the Kanto region (26.6%), followed by the Hokkaido and Tohoku regions (11.0%). The most common age group was 16 years old (36.8%), followed by 17 (32.2%) and 18 years old (19.3%). Significant differences were observed between the participants' gender, location of high school (p < 0.001), and age (p < 0.001); however, no significant difference was observed between gender and grade (p = 0.436). When comparing this study's data with the national data, significant differences were observed in high school location (p < 0.001) and subject grade level (p < 0.001).

TABLE 1.

Characteristics of survey responses by gender.

Characteristic Total (n = 41 357) Male (n = 19 321) Female (n = 21 630) Other or unknown (n = 406) p a National data b p c
Location of the high schools < 0.001 < 0.001
Hokkaido and Tohoku 11.0 11.8 10.3 12.1 10.9
Kanto 26.6 24.1 29.0 24.9 34.7
Hokuriku and Tokai 18.2 20.3 16.3 16.0 16.6
Kinki 16.4 15.3 17.2 20.0 16.6
Chugoku and Shikoku 12.7 12.8 12.7 9.4 9.0
Kyushu and Okinawa 15.1 15.6 14.6 17.7 12.2
Grade 0.436 < 0.001
First grade 39.3 39.4 39.1 41.1 33.4
Second grade 32.2 32.4 32.1 33.5 33.3
Third grade 28.5 28.2 28.8 24.5 33.3
Age < 0.001
15 11.5 11.1 11.9 10.8
16 36.8 37.0 36.6 37.7
17 32.2 32.3 32.2 31.3
18 19.3 19.4 19.3 17.2
≥ 19 0.1 0.1 0.1 3.0
a

p‐value for χ 2 test.

b

School Basic Survey 2020 based on the Statistics Act.

c

p‐value for χ 2‐test of goodness of fit.

3.2. Prevalence of OTC Drug Abuse and Substance Use

The estimated prevalence of OTC drug abuse, alcohol use, and cannabis use over the previous year is presented in Table 2. The prevalence of OTC drug use among the participants was 1.5%, that of alcohol was 12.5%, and that of marijuana was 0.1%. The prevalence of OTC drug abuse varied across subgroups. Regarding gender, the highest prevalences of OTC drug abuse were observed among “other” genders (8.3%), followed by females (1.7%) and males (1.2%). Regarding age, the highest prevalence was observed among ≥ 19 years (8.0%), followed by 15 years old (1.9%). No significant differences were observed regarding grades.

TABLE 2.

Prevalence of over‐the‐counter drug abuse and substance use.

Characteristic Past‐year, % (SE)
OTC drugs Alcohol Marijuana
Total 1.5 (0.1) 12.5 (0.7) 0.1 (0.0)
Gender
Male 1.2 (0.1) 14.2 (0.8) 0.1 (0.0)
Female 1.7 (0.2) 10.8 (0.9) 0.1 (0.0)
Other or unknown 8.3 (1.7) 23.4 (2.9) 3.3 (1.4)
p a < 0.001 < 0.001 < 0.001
Grade
First grade 1.5 (0.2) 9.5 (0.9) 0.1 (0.0)
Second grade 1.6 (0.2) 13.6 (0.8) 0.1 (0.0)
Third grade 1.7 (0.2) 16.8 (1.1) 0.3 (0.1)
p a 0.242 < 0.001 < 0.001
Age
15 1.9 (0.4) 9.2 (1.0) 0.1 (0.1)
16 1.3 (0.1) 10.2 (0.7) 0.1 (0.1)
17 1.6 (0.2) 14.5 (0.9) 0.2 (0.0)
18 1.6 (0.2) 17.1 (1.2) 0.2 (0.1)
≥ 19 8.0 (3.4) 45.6 (6.4) 1.0 (0.8)
p a < 0.001 < 0.001 < 0.001

Note: Estimate based on weighted data.

Abbreviations: OTC, over the counter; SE, standard error.

a

p‐value for Fisher's exact test.

The prevalence of alcohol use varied by gender; the prevalence was the highest among “other” genders (23.4%) and lowest among females (10.8%). Additionally, the prevalence of alcohol use increased with the age of the participants (first graders = 9.5%, second graders = 13.6%, and third graders = 16.8%); the prevalence was particularly high among participants aged ≥ 19 (45.6%).

Moreover, the prevalence of cannabis use also varied by gender; the highest prevalence was among “other” genders (3.3%) and equal among males (0.1%) and females (0.1%). Similar to the increase in the prevalence of alcohol use, an increase in the prevalence of cannabis use was observed with increased grades and age.

3.3. Predictors Associated With Self‐Reported Abuse of OTC Drugs

Table 3 presents the logistic regression analysis results, with OTC drug abuse over the past year as the dependent variable. VIF was employed to examine multicollinearity. NPS and cocaine use within the past year were excluded as variables from the logistic regression model because their VIF values exceeded 10. After excluding the two variables, the VIF was rechecked; the values of all remaining variables were below 10, indicating no multicollinearity. The p‐value of the Hosmer‐Lemeshow test was 0.463, confirming that the model was a good fit.

TABLE 3.

Predictors of self‐reported abuse of over‐the‐counter drugs among high school students in Japan.

Abused in the past year Not abused in the past year p AOR 95% CI
(n = 596) (n = 40 761)
n % n %
Age
15 76 1.6 4681 98.4 1.00 (reference)
16 206 1.4 15 014 98.6 0.128 0.81 0.62–1.06
17 189 1.4 13 140 98.6 0.052 0.76 0.57–1.00
18 118 1.5 7872 98.5 0.042 0.71 0.51–0.99
≥ 19 7 11.5 54 88.5 0.453 1.50 0.52–4.28
Gender
Male 234 1.2 19 087 98.8 1.00 (reference)
Female 329 1.5 21 301 98.5 < 0.001 1.50 1.25–1.80
Others or unknown 33 8.1 373 91.9 < 0.001 3.17 2.01–5.00
Satisfaction with school life
Very satisfied 184 1.1 16 612 98.9 1.00 (reference)
Satisfied 265 1.3 19 589 98.7 0.501 1.07 0.88–1.30
Dissatisfied 85 2.3 3630 97.7 0.009 1.45 1.10–1.92
Very dissatisfied 62 6.3 930 93.8 < 0.001 2.57 1.80–3.66
Close friends at school
No 58 4.1 1340 95.9 1.00 (reference)
Yes 538 1.3 39 421 98.7 0.051 0.68 0.47–1.00
Consultation with a friend
No 94 3.1 2958 96.9 1.00 (reference)
Yes 502 1.3 37 803 98.7 0.144 0.80 0.59–1.08
Extracurricular activities
Not participating 143 1.8 7658 98.2 1.00 (reference)
Negative participating 81 2.2 3668 97.8 0.228 1.19 0.90–1.60
Positive participating 224 1.1 20 339 98.9 0.052 0.80 0.63–1.00
Previously participated 148 1.6 9096 98.4 0.683 1.05 0.82–1.36
Average hours per day without parents
None 168 1.2 13 397 98.8 1.00 (reference)
Less than 1 h 91 1.3 6932 98.7 0.288 1.15 0.89–1.50
1–2 h 99 1.2 7998 98.8 0.870 1.02 0.79–1.32
2–3 h 66 1.2 5655 98.8 0.558 0.92 0.68–1.23
More than 3 h 172 2.5 6779 97.5 < 0.001 1.59 1.27–2.00
Consultation with father
Never 278 1.6 17 657 98.4 1.00 (reference)
Seldom 92 1.2 7648 98.8 0.424 1.11 0.86–1.44
Sometimes 87 1.2 7032 98.8 0.355 1.14 0.87–1.48
Often 37 1.2 3104 98.8 0.459 1.15 0.79–1.69
No father 102 1.9 5320 98.1 0.164 1.19 0.93–1.51
Consultation with mother
Never 191 2.1 9124 97.9 1.00 (reference)
Seldom 87 1.6 5415 98.4 0.409 0.89 0.67–1.18
Sometimes 168 1.2 14 101 98.8 0.005 0.71 0.56–0.90
Often 129 1.1 11 360 98.9 0.003 0.66 0.51–0.87
No mother 21 2.7 761 97.3 0.711 0.90 0.52–1.56
COVID‐19 related stress
None 75 1.4 5472 98.6 1.00 (reference)
Low 112 1.2 9622 98.8 0.775 1.05 0.77–1.43
Moderate 231 1.3 17 490 98.7 0.174 1.22 0.92–1.61
High 178 2.1 8177 97.9 0.004 1.53 1.14–2.05
Drug‐refusal skills
None 53 3.0 1716 97.0 1.00 (reference)
Low 44 5.6 735 94.4 0.007 1.88 1.19–2.97
Moderate 140 2.1 6435 97.9 0.972 0.99 0.69–1.42
High 359 1.1 31 875 98.9 < 0.001 0.57 0.41–0.79
Substance use within the past year
Alcohol 186 3.6 4984 96.4 < 0.001 2.18 1.78–2.67
Tobacco 60 12.4 423 87.6 < 0.001 2.46 1.68–3.62
Cannabis 30 54.5 25 45.5 0.003 4.11 1.61–10.49
Organic solvents 22 56.4 17 43.6 0.057 6.03 0.95–38.19
Methamphetamine 19 67.9 9 32.1 0.779 0.67 0.04–11.44
MDMA 21 65.6 11 34.4 0.159 4.12 0.57–29.63

Abbreviations: AOR, adjusted odds ratio; CI, confidence interval.

Regarding demographic variables, the risk of OTC drug abuse was significantly higher among females (AOR = 1.50; 95% CI = 1.25–1.80) and “other” genders (AOR = 3.17; 95% CI = 2.01–5.00) than among males. Regarding age, the risk of OTC drug abuse was significantly lower among 18‐year‐olds (AOR = 0.71; 95% CI = 0.51–0.99) than among 15‐year‐olds.

Regarding school‐related outcomes, a significant association was observed between satisfaction with school life and the risk of OTC drug abuse. The students who responded “dissatisfied” (AOR = 1.45; 95% CI = 1.10–1.92) or “very dissatisfied” (AOR = 2.57; 95% CI = 1.80–3.66) were at significantly higher risk of abuse than those who responded “very satisfied.” In addition, a significant association was observed between extracurricular activities and OTC drug abuse; students who positively participated in extracurricular activities had a significantly lower risk of abusing OTC drugs (AOR = 0.80; 95% CI = 0.63–1.00) than those who did not participate. However, no significant association was observed between having close friends or friends to talk to and the risk of OTC drug abuse.

Regarding the home life‐related results, a significant association was observed between hours spent in a day without parents and the risk of OTC drug abuse. Compared with students who reported “never” spending time without their parents, students who reported being without their parents for “three or more hours per day” (AOR = 1.59; 95% CI = 1.27–2.00) had a significantly higher risk of OTC drug abuse. Additionally, the participants were asked how often they consulted their parents as an index of communication with their parents. Students who consulted their mothers more frequently were at lower risk of OTC drug abuse: “sometimes” (AOR = 0.71; 95% CI = 0.56–0.90) and “often” (AOR = 0.66; 95% CI = 0.51–0.87). However, no significant association was observed with the frequency of paternal consultations. Regarding COVID‐19‐related stress, students who reported “high” COVID‐19‐related stress (AOR = 1.53; 95% CI = 1.15–2.05) had a significantly higher risk of abusing OTC drugs than students who reported “no” stress.

Finally, regarding substance use‐related results, significant increases in OTC drug abuse risk were observed for alcohol (AOR = 2.18; 95% CI = 1.78–2.67), tobacco (AOR = 2.46; 95% CI = 1.68–3.62), and cannabis (AOR = 4.11; 95% CI = 1.61–10.49); however, no significant associations were observed for organic solvents, methamphetamine, and MDMA. Regarding drug‐refusal skills, students who responded “high” (AOR = 0.57; 95% CI = 0.41–0.79) were at significantly lower risk of OTC drug abuse than those who responded “none.”

4. Discussion

4.1. Prevalence of OTC Drug Abuse

Based on the rapid increase in patients with OTC drug use disorders, such as abusing cough and cold medicines, at psychiatric facilities in Japan, this study aimed to explore the prevalence of OTC drug abuse among high school students nationwide and examine the psychosocial characteristics of students with a history of OTC drug abuse. The prevalence of OTC drug abuse among Japanese high school students over the past year was estimated to be approximately 1.5%, that is, approximately one in 60 students, suggesting that the OTC drug abuse problem is widespread throughout Japan.

In this study, the prevalence of OTC drug abuse did not increase with age and was found to be highest at age 15. Contrarily, the prevalence of alcohol and marijuana use increased with age. One explanation for these contradictory results could be the different legal regulations for each substance. Young 15‐year‐old high school students may have fewer barriers to obtaining OTC drugs, which are not illegal, than alcohol and marijuana, which are illegal and prohibited by law in Japan.

4.2. Findings Related to Gender Difference

This study revealed several findings regarding the psychosocial characteristics of high school students who abused OTC drugs. First, a gender difference was observed in the prevalence of OTC drug abuse, with females having a significantly higher prevalence of OTC drug abuse than males. Previous studies on gender differences in substance use during adolescence found that females who experience disrupted parent–child relationships and chaotic home environments are more likely to use drugs than males in similar environments [30]. Additionally, studies on adolescents receiving substance abuse treatment suggest that females may need stronger and larger doses of drugs than males to cope with their traumatic symptoms [31]. These studies indicate that stress and trauma symptoms underlying OTC drug abuse are more prevalent in females, aiding interpretation of the current findings.

Additionally, regarding gender, this study found that students who identified as “unknown” or “other” had an even higher prevalence of OTC drug abuse than females. Students who responded to the gender question as “other” or “unknown” were more likely to be identified as sexual minorities. These results may suggest that students from sexual minority backgrounds experience more life stress and psychological trauma than heterosexual students. Previous studies examining the relationship between sexual orientation and adolescent substance use reported that LGBT youth have significantly higher rates of drug use than heterosexual youth [32], which assists in explaining this study's results.

4.3. Findings Related to Risk Factors

Second, regarding the risk factors for OTC drug abuse, the results indicated that high school students who were dissatisfied with their school life were at a higher risk of OTC drug abuse. Previous studies found that adolescents who withdrew from their school network and have older friends outside school are at a higher risk of drug use and that socially indifferent young individuals are more vulnerable to drinking and smoking than sociable young individuals [33, 34]. This study's results suggest that Japanese high school students who abuse OTC drugs are isolated in their school life and that withdrawal from their school network, including their friendships, may increase the risk of OTC drug abuse.

Moreover, this study found that high school students who spent more time without their parents at home were at a higher risk of OTC drug abuse. This may be related to the preventive effects of parental supervision. For example, a longitudinal study that followed a large group of adolescents aged 12–23 years reported that parental supervision was a predictor of drug use during early adolescence [25]. This study assessed parental supervision by asking the participants how much time they spent without a guardian. The relationship between parental monitoring and adolescent substance use risk is sometimes discordant between child and parental reports. However, positive family management predicts substance use only through child reports and not parental reports [35]. Given these previous findings, this study suggests that high school students' assessment of parental monitoring may predict the risk of OTC drug abuse.

Furthermore, the results indicated that high school students with high levels of COVID‐19‐related stress were at a significantly higher risk of OTC drug abuse. Previous studies found that drug use significantly increased during the pandemic and that drug use can be considered as a way to cope with pandemic‐related anxiety [26]. This study was conducted in 2021, when many young individuals, including high school students, were required to abstain from schools and stay at home as a preventive measure against COVID‐19. This study's findings suggest that stress and loneliness may have contributed to the increased risk of OTC drug abuse among high school students during the COVID‐19 pandemic.

4.4. Findings Related to Protective Factors

Third, regarding protective factors, this study found that the risk of abusing OTC drugs is significantly reduced when students participate in extracurricular activities positively. Previous studies found that school‐based extracurricular activities such as physical, cultural, and artistic activities provide opportunities for adolescents to enhance their strength and build skills with their peers [23, 36]. The results suggested that bonding with peers through extracurricular activities reduces feelings of isolation and acts as a protective factor against OTC drug abuse, which was consistent with previous studies [23].

Regarding the parent–child relationship, this study found that the more frequently children consulted their mothers about their worries, the lower the risk of OTC drug abuse. In contrast, no significant association was found between the frequency of consultations with fathers and OTC drug abuse. Research on adolescent substance use and parent–child relationships highlights gender‐specific variations in communication with fathers and mothers [37]. Moreover, a follow‐up study of junior high school students in Hong Kong reported that the mother–child relationship during adolescence was the most important and robust long‐term predictor of drug use [38]. The results indicate that the mother–child relationship during adolescence has a greater influence on drug use behavior than the father–child relationship, and these results suggest that a close relationship with one's mother may be a protective factor against OTC drug abuse among high school students.

Furthermore, this study assessed refusal self‐efficacy using a Likert scale, and the results indicated that students with high self‐efficacy had a significantly lower risk of OTC drug abuse than those with low self‐efficacy. Although it has been pointed out that research results regarding the relationship between adolescent drug use and low refusal skills are inconsistent [39], this study's results suggest that improving drug‐refusal skills may reduce the risk of substance use. Preventive education in schools is one of the most important measures against adolescent drug problems, and refusal skills in substance use are among the most important social skills during adolescence [40]. Systematic reviews on the effectiveness of school‐based prevention programs reported that programs focusing on social skills are more effective for prevention than regular curricula [41].

In Japan, drug abuse prevention education is part of the elementary to high school curriculum and is predominantly taught in health and physical education classes. However, the Japanese curriculum mainly focuses on illicit drugs, such as methamphetamine and marijuana, and does not include the prevention of OTC drug abuse. This study found that the prevalence of OTC drug abuse among high school students was significantly higher than that of marijuana, the most commonly abused controlled substance. Therefore, the educational curriculum does not match the actual situation of drug abuse among the youth. Consequently, the educational curriculum requires review, and education on use disorders and acute poisoning due to OTC drug abuse should be included.

4.5. Limitations of This Study

This study has some potential limitations that require caution when interpreting the results. The first is regarding the data's representativeness. This study randomly selected schools from all over Japan; however, only regular high schools with daytime classes were included. Therefore, students attending nighttime and online high schools were not included. Previous studies reported that the prevalence of alcohol, smoking, and marijuana use among nighttime school students was significantly higher than that among regular high school students [42]. In addition, nighttime school students were more likely to have experienced bullying or been absent from school than regular high school students [43]. Based on these previous studies, the actual prevalence of OTC drug abuse among high school students, including nighttime and online high schools, may be higher than the results of this study. In addition, the response rate in this study was low, and the data obtained may not represent all high school students nationwide. The low response rate is believed to be owing to the survey being conducted during the period when a state of emergency was declared due to the COVID‐19 pandemic, and schools did not have sufficient capacity to accept surveys from outside.

Second, this was a cross‐sectional study. Although this study examined the association between OTC drug abuse and various psychosocial factors among high school students, the findings did not necessarily prove causal relationships among the variables. Future follow‐up studies with a time course are required to prove causal relationships among the variables.

Third, the primary outcome of this study, the abuse of OTC drugs, was only assessed using self‐reporting. In addition, this study only collected information about drug abuse within the past year and did not provide detailed information such as the frequency of abuse, dosage per use, or specific brand names or ingredients. Self‐reported assessments of drug use are more prone to under‐reporting bias than assessments based on biological markers such as urine or hair tests [44, 45]. However, self‐reported underreporting is more likely to be influenced by recent experiences, such as drug use within 72 h, and by assessments of substances that are more stigmatized, such as drug offenses [46]. This study assessed self‐reported experiences of abuse within the past year, and there were no legal prohibitions against the abuse of OTC drugs. Therefore, an underreporting bias may have occurred in this study owing to self‐reports of OTC drug abuse; however, the degree of bias can be considered relatively small.

4.6. Clinical Implications

Despite these limitations, this study is the first in Asia to use nationwide data, based on random sampling, to estimate the prevalence of OTC drug abuse among high school students and to identify predictors related to their lifestyle. Therefore, this study has important public health policy implications. The findings may be useful in examining how OTC drugs are marketed to adolescents and in developing effective prevention education programs in schools. Furthermore, regarding the implications for psychiatric clinical practice, understanding the risk factors identified in this study may assist psychiatrists and pediatricians in recognizing early relapse risk in adolescents with OTC drug abuse problems. However, understanding the protective factors may help strengthen support for adolescents and their families connected to drug addiction treatment.

5. Conclusions

The prevalence of OTC drug abuse in the past year among Japanese high school students was estimated to be approximately 1.5%. This corresponds to approximately one in 60 high school students, suggesting that the OTC drug abuse problem is widespread throughout Japan. Isolation in both school and home may be a risk factor for OTC drug abuse among adolescents, whereas connections with parents and friends may have protective effects. Therefore, it is necessary to develop effective educational and treatment programs for OTC drug abuse among adolescents.

Author Contributions

T.S. and S.I. designed the basic nationwide survey. T.M. obtained funding. T.S., S.I., K.K, and K.T. designed the questionnaire. T.S., S.I., and M.K. recruited participants, collected data, and created the database. T.S. conceived the study, performed the statistical analyses, interpreted the results, and wrote the manuscript. All authors revised and contributed to the final version of the manuscript. All authors have read and approved the final manuscript for publication.

Ethics Statement

This study followed Japan's Ethical Guidelines for Medical and Biological Research Involving Human Subjects and conformed to the provisions of the Declaration of Helsinki. The study protocol was reviewed and approved by the Ethics Committee of the National Center of Neurology and Psychiatry (Approval no.: A2018‐055).

Consent

The participants were informed in advance of the organization and purpose of the research, the voluntary nature of responses to the survey, and how the data would be used. The survey description was published on the Internet as a public notice and at the beginning of the questionnaire, which the teachers read before administering the survey. In this study, the informed consent procedure was omitted because the participants had the opportunity to refuse to participate.

Conflicts of Interest

The authors declare no conflicts of interest.

Acknowledgments

We thank the students at each high school who responded to the survey, and the teachers who cooperated in conducting the survey. The authors thank Mr. Matsumura Takahiro of WAKARA Co. (Tokyo, Japan) for his contribution to the statistical procedures used in this study. The authors also thank Mr. Yuji Takahashi and Mr. Yutaka Iida of Shin Joho Center Inc. (Tokyo, Japan) for their assistance with questionnaire distribution, collection, and data input.

Funding: This study was supported by Japan's Ministry of Health, Labour and Welfare: Research Grant for the Division of Research, National Center for Addiction Services Administration (No. 202204).

Data Availability Statement

This study's dataset cannot be made publicly available, because data‐sharing approval has not been obtained from the Ethics Committee of the National Center of Neurology and Psychiatry. However, while raw data are not available, all the survey questionnaires, descriptive statistics for all the variables, cross‐tabulation results (by gender and grade level), and estimation‐related results are publicly accessible on the first author's institutional website (https://www.ncnp.go.jp/nimh/yakubutsu/report/pdf/highschool2021_ver2.pdf).

References

  • 1. Schifano F., Chiappini S., Miuli A., et al., “Focus on Over‐the‐Counter Drugs' Misuse: A Systematic Review on Antihistamines, Cough Medicines, and Decongestants,” Frontiers in Psychiatry 12 (2021): 657397. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Levine D. A., “‘Pharming’: The Abuse of Prescription and Over‐the‐Counter Drugs in Teens,” Current Opinion in Pediatrics 19, no. 3 (2007): 270–274. [DOI] [PubMed] [Google Scholar]
  • 3. Abraham O. and Chmielinski J., “Adolescents' Misuse of Over‐the‐Counter Medications: The Need for Pharmacist‐Led Intervention,” Innovations in Pharmacy 9, no. 3 (2018): 1–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Bryner J. K., Wang U. K., Hui J. W., Bedodo M., MacDougall C., and Anderson I. B., “Dextromethorphan Abuse in Adolescence: An Increasing Trend: 1999–2004,” Archives of Pediatrics & Adolescent Medicine 160, no. 12 (2006): 1217–1222. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Romanelli F. and Smith K. M., “Dextromethorphan Abuse: Clinical Effects and Management,” Journal of the American Pharmacists Association 49, no. 2 (2009): e20–e27. [DOI] [PubMed] [Google Scholar]
  • 6. Siu A. and Drachtman R., “Dextromethorphan: A Review of N‐Methyl‐D‐Aspartate Receptor Antagonist in the Management of Pain,” CNS Drug Reviews 13, no. 1 (2007): 96–106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Carter L. P., Reissig C. J., Johnson M. W., Klinedinst M. A., Griffiths R. R., and Mintzer M. Z., “Acute Cognitive Effects of High Doses of Dextromethorphan Relative to Triazolam in Humans,” Drug and Alcohol Dependence 128, no. 3 (2013): 206–213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Logan B. K., Yeakel J. K., Goldfogel G., Frost M. P., Sandstrom G., and Wickham D. J., “Dextromethorphan Abuse Leading to Assault, Suicide, or Homicide,” Journal of Forensic Sciences 57, no. 5 (2012): 1388–1394. [DOI] [PubMed] [Google Scholar]
  • 9. American College of Preventive Medicine , “Use, Abuse, Misuse, and Disposal of Prescription Pain Medication Clinical Reference,” https://cdn.ymaws.com/acpm.site‐ym.com/resource/resmgr/timetools‐files/painmedsclinicalreference.pdf.
  • 10. Matsumoto T. and Imamura F., “Self‐Injury in Japanese Junior and Senior High‐School Students: Prevalence and Association With Substance Use,” Psychiatry and Clinical Neurosciences 62, no. 1 (2008): 123–125. [DOI] [PubMed] [Google Scholar]
  • 11. Shimane T., Hidaka Y., Wada K., and Funada M., “Ecstasy (3, 4‐Methylenedioxymethamphetamine) Use Among Japanese Rave Population,” Psychiatry and Clinical Neurosciences 67, no. 1 (2013): 12–19. [DOI] [PubMed] [Google Scholar]
  • 12. Chester L. A., Valmaggia L. R., Kempton M. J., et al., “Influence of Cannabis Use on Incidence of Psychosis in People at Clinical High Risk,” Psychiatry and Clinical Neurosciences 77, no. 9 (2023): 469–477. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Fingleton N. A., Watson M. C., Duncan E. M., and Matheson C., “Non‐Prescription Medicine Misuse, Abuse and Dependence: A Cross‐Sectional Survey of the UK General Population,” Journal of Public Health 38, no. 4 (2016): 722–730. [DOI] [PubMed] [Google Scholar]
  • 14. Chiappini S., Ceci F., Mosca A., et al., “Knowledge and Use of Over‐the‐Counter Drugs in Italy: An Exploratory Survey‐Based Study in the General Population,” Current Neuropharmacology 21, no. 1 (2023): 133–141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Shimane T., Inoura S., and Matsumoto T., “Proposed Indicators for Sustainable Development Goals (SDGs) in Drug Abuse Fields Based on National Data From Japan,” Journal of the National Institute of Public Health 70, no. 3 (2021): 252–261. [Google Scholar]
  • 16. Usami T., Okita K., Shimane T., and Matsumoto T., “Comparison of Patients With Benzodiazepine Receptor Agonist‐Related Psychiatric Disorders and Over‐the‐Counter Drug‐Related Psychiatric Disorders Before and After the COVID‐19 Pandemic: Changes in Psychosocial Characteristics and Types of Abused Drugs,” Neuropsychopharmacology Reports 44, no. 2 (2024): 437–446. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Kawakami T., Takiyama Y., Yanaka I., et al., “Chronic Bromvalerylurea Intoxication: Dystonic Posture and Cerebellar Ataxia due to Nonsteroidal Anti‐Inflammatory Drug Abuse,” Internal Medicine 37, no. 9 (1998): 788–791. [DOI] [PubMed] [Google Scholar]
  • 18. Ishikura K., Katayama K., Hara A., et al., “A Case of Acute Bromvalerylurea Intoxication That Was Successfully Treated With Direct Hemoperfusion,” CEN Case Reports 11, no. 2 (2022): 269–272. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Miech R. A., Johnston L. D., Patrick M. E., et al., Monitoring the Future National Survey Results on Drug Use, 1975–2022: Secondary School Students (Institute for Social Research, University of Michigan, 2023). [Google Scholar]
  • 20. Shimane T., Inoura S., Kitamura M., et al., The Nationwide High School Survey on Drug Use and Lifestyle 2021 (National Center for Addiction Services Administration, 2022), https://www.ncnp.go.jp/nimh/yakubutsu/report/pdf/highschool2021_ver2.pdf. [Google Scholar]
  • 21. “Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices,” https://www.japaneselawtranslation.go.jp/ja/laws/view/3213.
  • 22. Tan K., Davis J. P., Smith D. C., and Yang W., “Individual, Family, and School Correlates Across Patterns of High School Poly‐Substance Use,” Substance Use & Misuse 55, no. 5 (2020): 743–751. [DOI] [PubMed] [Google Scholar]
  • 23. Moilanen K. L., Markstrom C. A., and Jones E., “Extracurricular Activity Availability and Participation and Substance Use Among American Indian Adolescents,” Journal of Youth and Adolescence 43, no. 3 (2014): 454–469. [DOI] [PubMed] [Google Scholar]
  • 24. Forster M., Grigsby T. J., Bunyan A., Unger J. B., and Valente T. W., “The Protective Role of School Friendship Ties for Substance Use and Aggressive Behaviors Among Middle School Students,” Journal of School Health 85, no. 2 (2015): 82–89. [DOI] [PubMed] [Google Scholar]
  • 25. Van Ryzin M. J., Fosco G. M., and Dishion T. J., “Family and Peer Predictors of Substance Use From Early Adolescence to Early Adulthood: An 11‐Year Prospective Analysis,” Addictive Behaviors 37, no. 12 (2012): 1314–1324. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Taylor S., Paluszek M. M., Rachor G. S., McKay D., and Asmundson G. J. G., “Substance Use and Abuse, COVID‐19‐Related Distress, and Disregard for Social Distancing: A Network Analysis,” Addictive Behaviors 114 (2021): 106754. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Scheier L. M., Botvin G. J., Diaz T., and Griffin K. W., “Social Skills, Competence, and Drug Refusal Efficacy as Predictors of Adolescent Alcohol Use,” Journal of Drug Education 29, no. 3 (1999): 251–278. [DOI] [PubMed] [Google Scholar]
  • 28. Peters L. W. H., Wiefferink C. H., Hoekstra F., Buijs G. J., Ten Dam G. T. M., and Paulussen T. G. W. M., “A Review of Similarities Between Domain‐Specific Determinants of Four Health Behaviors Among Adolescents,” Health Education Research 24, no. 2 (2009): 198–223. [DOI] [PubMed] [Google Scholar]
  • 29. “School Basic Survey, e‐Stat: Portal Site for Japanese Government Statistics,” https://www.e‐stat.go.jp/en/statistics/00400001.
  • 30. Dakof G. A., “Understanding Gender Differences in Adolescent Drug Abuse: Issues of Comorbidity and Family Functioning,” Journal of Psychoactive Drugs 32, no. 1 (2000): 25–32. [DOI] [PubMed] [Google Scholar]
  • 31. Stevens S. J., Murphy B. S., and McKnight K., “Traumatic Stress and Gender Differences in Relationship to Substance Abuse, Mental Health, Physical Health, and HIV Risk Behavior in a Sample of Adolescents Enrolled in Drug Treatment,” Child Maltreatment 8, no. 1 (2003): 46–57. [DOI] [PubMed] [Google Scholar]
  • 32. Marshal M. P., Friedman M. S., Stall R., et al., “Sexual Orientation and Adolescent Substance Use: A Meta‐Analysis and Methodological Review,” Addiction 103, no. 4 (2008): 546–556. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Copeland M., Fisher J. C., Moody J., and Feinberg M. E., “Different Kinds of Lonely: Dimensions of Isolation and Substance Use in Adolescence,” Journal of Youth and Adolescence 47, no. 8 (2018): 1755–1770. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Niño M. D., Cai T., and Ignatow G., “Social Isolation, Drunkenness, and Cigarette Use Among Adolescents,” Addictive Behaviors 53 (2016): 94–100. [DOI] [PubMed] [Google Scholar]
  • 35. Fleming C. B., Mason W. A., Thompson R. W., Haggerty K. P., and Gross T. J., “Child and Parent Report of Parenting as Predictors of Substance Use and Suspensions From School,” Journal of Early Adolescence 36, no. 5 (2016): 625–645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Mahoney J. L., “School Extracurricular Activity Participation as a Moderator in the Development of Antisocial Patterns,” Child Development 71, no. 2 (2000): 502–516. [DOI] [PubMed] [Google Scholar]
  • 37. Luk J. W., Farhat T., Iannotti R. J., and Simons‐Morton B. G., “Parent‐Child Communication and Substance Use Among Adolescents: Do Father and Mother Communication Play a Different Role for Sons and Daughters?,” Addictive Behaviors 35, no. 5 (2010): 426–431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. Shek D. T. L., Zhu X., Dou D., and Chai W., “Influence of Family Factors on Substance Use in Early Adolescents: A Longitudinal Study in Hong Kong,” Journal of Psychoactive Drugs 52, no. 1 (2020): 66–76. [DOI] [PubMed] [Google Scholar]
  • 39. Petraitis J., Flay B. R., Miller T. Q., Torpy E. J., and Greiner B., “Illicit Substance Use Among Adolescents: A Matrix of Prospective Predictors,” Substance Use & Misuse 33, no. 13 (1998): 2561–2604. [DOI] [PubMed] [Google Scholar]
  • 40. Botvin G. J. and Griffin K. W., “School‐Based Programmes to Prevent Alcohol, Tobacco, and Other Drug Use,” International Review of Psychiatry 19, no. 6 (2007): 607–615. [DOI] [PubMed] [Google Scholar]
  • 41. Faggiano F., Minozzi S., Versino E., and Buscemi D., “Universal School‐Based Prevention for Illicit Drug Use,” Cochrane Database of Systematic Reviews 2014, no. 12 (2014): CD003020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42. Shimane T. and Wada K., “Substance Use Among Night High School Students in Japan” [in Japanese], Nihon Arukōru Yakubutsu Igakkai Zasshi 42, no. 3 (2007): 152–164. [PubMed] [Google Scholar]
  • 43. Shimane T. and Wada K., “Associations Between Substance Use and Problem Behaviors Among Night High School Students in Japan” [in Japanese], Japanese Bulletin of Social Psychiatry 17 (2009): 233–244. [Google Scholar]
  • 44. Ashrafi S., Aminisani N., Soltani S., Sarbakhsh P., Shamshirgaran S. M., and Rashidi M. R., “The Validity of Self‐Reported Drug Use With Urine Test: Results From the Pilot Phase of Azar Cohort Study,” Health Promotion Perspective 8, no. 3 (2018): 225–229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45. G. S. Yacoubian, Jr. , VanderWall K. L., Johnson R. J., Urbach B. J., and Peters R. J., “Comparing the Validity of Self‐Reported Recent Drug Use Between Adult and Juvenile Arrestees,” Journal of Psychoactive Drugs 35, no. 2 (2003): 279–284. [DOI] [PubMed] [Google Scholar]
  • 46. Khalili P., Nadimi A. E., Baradaran H. R., et al., “Validity of Self‐Reported Substance Use: Research Setting Versus Primary Health Care Setting,” Substance Abuse Treatment, Prevention, and Policy 16, no. 1 (2021): 66. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

This study's dataset cannot be made publicly available, because data‐sharing approval has not been obtained from the Ethics Committee of the National Center of Neurology and Psychiatry. However, while raw data are not available, all the survey questionnaires, descriptive statistics for all the variables, cross‐tabulation results (by gender and grade level), and estimation‐related results are publicly accessible on the first author's institutional website (https://www.ncnp.go.jp/nimh/yakubutsu/report/pdf/highschool2021_ver2.pdf).


Articles from Neuropsychopharmacology Reports are provided here courtesy of Wiley

RESOURCES